The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.
 
Mehmet Akce
No Relationships to Disclose
 
Olatunji B. Alese
Research Funding - Acetylon Pharmaceuticals; Bristol-Myers Squibb; Five Prime Therapeutics
Travel, Accommodations, Expenses - Lilly
 
Walid Labib Shaib
No Relationships to Disclose
 
Christina Sing-Ying Wu
Honoraria - BioTheranostics
Consulting or Advisory Role - Bayer
Research Funding - Amgen
Travel, Accommodations, Expenses - Merck
 
Gregory B Lesinski
No Relationships to Disclose
 
Bassel F. El-Rayes
Consulting or Advisory Role - BTG; Genentech/Roche; Merrimack; Merrimack
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Novartis (Inst); Pfizer (Inst); PPD (Inst); Taiho Pharmaceutical (Inst)